Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $96.0200 (-2.37%) ($95.4120 - $100.8500) on Tue. Sep. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.39% (three month average) | RSI | 23 | Latest Price | $96.0200(-2.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -2.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(49%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.195% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IGOV(-7%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.195% (StdDev 2.39%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $91.07(-5.16%) | Inflection Point | Yes | Resistance Level | $104 | 5 Day Moving Average | $99.47(-3.47%) | 10 Day Moving Average | $99.86(-3.85%) | 20 Day Moving Average | $104(-7.67%) | To recent high | -24.2% | To recent low | 0% | Market Cap | $1.543b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |